{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:19:18Z","timestamp":1792189158252,"version":"4.4.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s11926-020-0883-0","type":"journal-article","created":{"date-parts":[[2020,2,5]],"date-time":"2020-02-05T03:02:22Z","timestamp":1580871742000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Pneumocystis jirovecii Pneumonia and Other Infections in Idiopathic Inflammatory Myositis"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1429-8392","authenticated-orcid":false,"given":"Christopher A.","family":"Mecoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonye K.","family":"Danoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,5]]},"reference":[{"key":"883_CR1","doi-asserted-by":"publisher","first-page":"e0192491","DOI":"10.1371\/journal.pone.0192491","volume":"23","author":"C Wu","year":"2018","unstructured":"Wu C, Wang Q, He L, Yang E, Zeng X. Hospitalization mortality and associated risk factors in patients with polymyositis and dermatomyositis: a retrospective case-control study. PLoS One. 2018;23:e0192491.","journal-title":"PLoS One"},{"key":"883_CR2","doi-asserted-by":"publisher","first-page":"e0154441","DOI":"10.1371\/journal.pone.0154441","volume":"26","author":"JM Peng","year":"2016","unstructured":"Peng JM, Du B, Wang Q, Weng L, Hu XY, Wu CY, et al. Dermatomyositis and Polymyositis in the intensive care unit: a single-center retrospective cohort study of 102 patients. PLoS One. 2016;26:e0154441.","journal-title":"PLoS One"},{"key":"883_CR3","first-page":"820","volume":"34","author":"M Amaral Silva","year":"2016","unstructured":"Amaral Silva M, Cogollo E, Isenberg DA. Why do patients with myositis die? A retrospective analysis of a single-centre cohort. Clin Exp Rheumatol. 2016;34:820\u20136.","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"883_CR4","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1002\/acr.22501","volume":"67","author":"Sara G. Murray","year":"2015","unstructured":"Murray SG, Schmajuk G, Trupin L, Lawson E, Cascino M, Barton J et al. A population-based study of infection-related hospital mortality in patients with dermatomyositis\/polymyositis. Arthritis Care Res (Hoboken). 2015;67:673\u201380.","journal-title":"Arthritis Care & Research"},{"key":"883_CR5","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.semarthrit.2010.08.003","volume":"41","author":"I Marie","year":"2011","unstructured":"Marie I, M\u00e9nard JF, Hachulla E, Ch\u00e9rin P, Benveniste O, Tiev K, et al. Infectious complications in polymyositis and dermatomyositis: a series of 279 patients. Semin Arthritis Rheum. 2011;41:48\u201360. https:\/\/doi.org\/10.1016\/j.semarthrit.2010.08.003.","journal-title":"Semin Arthritis Rheum"},{"key":"883_CR6","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/mus.26032","volume":"57","author":"DE Prior","year":"2018","unstructured":"Prior DE, Nurre E, Roller SL, Kline D, Panara R, Stino AM, et al. Infections and the relationship to treatment in neuromuscular autoimmunity. Muscle Nerve. 2018;57:927\u201331. https:\/\/doi.org\/10.1002\/mus.26032.","journal-title":"Muscle Nerve"},{"key":"883_CR7","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1016\/j.amjmed.2014.07.010","volume":"127","author":"P Fillatre","year":"2014","unstructured":"Fillatre P, Decaux O, Jouneau S, Revest M, Gacouin A, Robert-Gangneux F, et al. Incidence of Pneumocystis jiroveci pneumonia among groups at risk in HIV-negative patients. Am J Med. 2014;127:e11\u20137.","journal-title":"Am J Med"},{"key":"883_CR8","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s10067-006-0441-9","volume":"26","author":"ME Falagas","year":"2007","unstructured":"Falagas ME, Manta KG, Betsi GI, Pappas G. Infection-related morbidity and mortality in patients with connective tissue diseases: a systematic review. Clin Rheumatol. 2007;26:663\u201370.","journal-title":"Clin Rheumatol"},{"key":"883_CR9","first-page":"671","volume":"35","author":"CA Mecoli","year":"2017","unstructured":"Mecoli CA, Saylor D, Gelber AC, Christopher-Stine L. Pneumocystis jiroveci pneumonia in rheumatic disease: a 20-year single-centre experience. Clin Exp Rheumatol. 2017;35:671\u20133.","journal-title":"Clin Exp Rheumatol"},{"key":"883_CR10","doi-asserted-by":"publisher","first-page":"792","DOI":"10.3899\/jrheum.090843","volume":"37","author":"D Cettomai","year":"2010","unstructured":"Cettomai D, Gelber AC, Christopher-Stine L. A survey of rheumatologists\u2019 practice for prescribing pneumocystis prophylaxis. J Rheum. 2010;37:792\u20139.","journal-title":"J Rheum"},{"key":"883_CR11","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.semarthrit.2018.10.018","volume":"48","author":"G Schmajuk","year":"2019","unstructured":"Schmajuk G, Jafria K, Evansa M, Shiboskic S, Gianfrancesco M, Izadi Z, et al. Pneumocystis jiroveci pneumonia (PJP) prophylaxis patterns among patients with rheumatic diseases receiving high-risk immunosuppressant drugs. Semin Arthritis Rheum. 2019;48:1087\u201392.","journal-title":"Semin Arthritis Rheum"},{"key":"883_CR12","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.semarthrit.2016.09.009","volume":"46","author":"S Tadros","year":"2017","unstructured":"\u2022 Tadros S, Teichtahl AJ, Wicks IP CS. Pneumocystis jirovecii pneumonia in systemic autoimmune rheumatic disease: a case-control study. Semin Arthritis Rheum. 2017;46:804\u20139 Provides a summary of different PJP prophylaxis recommendations from several other groups.","journal-title":"Semin Arthritis Rheum"},{"key":"883_CR13","first-page":"490","volume":"36","author":"G Baulier","year":"2018","unstructured":"Baulier G, Issa N, Gabriel F, Accoceberry I, Camou F, Duffau P. Guidelines for prophylaxis of Pneumocystis pneumonia cannot rely solely on CD4-cell count in autoimmune and inflammatory diseases. Clin Exp Rheumatol. 2018;36:490\u20133.","journal-title":"Clin Exp Rheumatol"},{"key":"883_CR14","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1136\/annrheumdis-2017-211796","volume":"77","author":"JW Park","year":"2018","unstructured":"Park JW, Curtis JR, Moon J, Song YW, Kim S, Lee EB. Prophylactic effect of trimethoprim-sulfamethaxazole for pneumocystis pneumonia in patients with rheumatic diseases exposed to prolonged high-dose glucocorticoids. Ann Rheum Dis. 2018;77:664\u20139.","journal-title":"Ann Rheum Dis"},{"key":"883_CR15","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1164\/rccm.2008-740ST","volume":"183","author":"AH Limper","year":"2011","unstructured":"Limper AH, Knox KS, Sarosi GA, et al. An official American Thoracic Society statement: treatment of fungal infections in adult pulmonary and critical care patients. Am J Respir Crit Care Med. 2011;183:96\u2013128.","journal-title":"Am J Respir Crit Care Med"},{"key":"883_CR16","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1136\/annrheumdis-2017-212588","volume":"77","author":"KL Winthrop","year":"2018","unstructured":"\u2022\u2022 Winthrop KL, Baddley JW. Pneumocystis and glucocorticoid use: to prophylax or not to prophylax (and when?); that is the question. Ann Rheum Dis. 2018;77:631\u20133 Provides context for prior PJP recommendations and puts forth another set of recommendations based both on evidence and expert opinion.","journal-title":"Ann Rheum Dis"},{"key":"883_CR17","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/00005792-200303000-00002","volume":"82","author":"M Viguier","year":"2003","unstructured":"Viguier M, Fou\u00e9r\u00e9 S, de la Salmoni\u00e8re P, Rabian C, Lebbe C, Dubertret L, et al. Peripheral blood lymphocyte subset counts in patients with dermatomyositis: clinical correlations and changes following therapy. Medicine (Baltimore). 2003;82:82\u20136.","journal-title":"Medicine (Baltimore)"},{"key":"883_CR18","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1136\/jnnp.2006.092353","volume":"77","author":"S Vulliemoz","year":"2006","unstructured":"Vulliemoz S, Lurati-Ruiz F, Borruat FX, Delavelle J, Koralnik IJ, Kuntzer T, et al. Favourable outcome of progressive multifocal leucoencephalopathy in two patients with dermatomyositis. J Neurol Neurosurg Psychiatry. 2006;77:1079\u201382.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"883_CR19","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1002\/art.34468","volume":"64","author":"ES Molloy","year":"2012","unstructured":"Molloy ES, Calabrese LH. Progressive multifocal leukoencephalopathy associated with immunosuppressive therapy in rheumatic diseases: evolving role of biologic therapies. Arthritis Rheum. 2012;64:3043\u201351.","journal-title":"Arthritis Rheum"},{"key":"883_CR20","doi-asserted-by":"publisher","first-page":"519","DOI":"10.2169\/internalmedicine.54.2748","volume":"54","author":"M Belhassen-Garcia","year":"2015","unstructured":"Belhassen-Garcia M, R\u00e1bano-Guti\u00e9rrez A, Velasco-Tirado V, Romero-Alegria A, P\u00e9rez-Garcia ML, Martin-Oterino JA. Atypical progressive multifocal leukoencephalopathy in a patient with antisynthetase syndrome. Intern Med. 2015;54:519\u201324. https:\/\/doi.org\/10.2169\/internalmedicine.54.2748.","journal-title":"Intern Med"},{"key":"883_CR21","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.3899\/jrheum.111126","volume":"39","author":"M Dastmalchi","year":"2012","unstructured":"Dastmalchi M, Laki J, Lundberg IE, Iacobaeus E. Progressive multifocal leukoencephalopathy in a patient with polymyositis: case report and literature review. J Rheumatol. 2012;39:1299\u2013303.","journal-title":"J Rheumatol"},{"key":"883_CR22","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1136\/jnnp.2009.187666","volume":"81","author":"S Gheuens","year":"2010","unstructured":"Gheuens S, Pierone G, Peeters P, Koralnik IJ. Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression. J Neurol Neurosurg Psychiatry. 2010;81:247\u201354.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"883_CR23","unstructured":"Center for Disease Control and Prevention. https:\/\/www.cdc.gov\/shingles\/index.html. Accessed 15 June 2019."},{"issue":"28","key":"883_CR24","doi-asserted-by":"publisher","first-page":"e1138","DOI":"10.1097\/MD.0000000000001138","volume":"94","author":"Shin-Yi Tsai","year":"2015","unstructured":"Tsai SY, Lin CL, Wong YC, Yang TY, Kuo CF, Cheng JM et al. Increased Risk of Herpes Zoster Following Dermatomyositis and Polymyositis: A Nationwide Population-Based Cohort Study. Medicine (Baltimore). 2015;94:e1138.","journal-title":"Medicine"},{"key":"883_CR25","unstructured":"Center for Disease Control and Prevention. https:\/\/www.cdc.gov\/vaccines\/vpd\/flu\/index.html. Accessed 15 June 2019."},{"key":"883_CR26","unstructured":"Center for Disease Control and Prevention. https:\/\/www.cdc.gov\/vaccines\/vpd\/pneumo\/index.html. Accessed 15 June 2019."}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-020-0883-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11926-020-0883-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-020-0883-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T22:17:23Z","timestamp":1744150643000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11926-020-0883-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["883"],"URL":"https:\/\/doi.org\/10.1007\/s11926-020-0883-0","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"5 February 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"7"}}